VEGF signaling in pancreatic cancer can lead to malignant transformation of the pancreas when ligands bind with VEGFRs. Growth factors, genetic modifications, and hypoxia are some of the complicated processes that control the production of VEGF in tumor cells. (Nandy and Mukhopadhyay, 2011). This evidence concerns the gene VEGFA and pancreatic neoplasm.